NASDAQ:IRMD - Iradimed Stock Price, Forecast & News

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

Iradimed Corp (NASDAQ:IRMD) issued its quarterly earnings data on Thursday, February, 6th. The medical equipment provider reported $0.30 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.10. The medical equipment provider had revenue of $10.89 million for the quarter, compared to analysts' expectations of $10.96 million. Iradimed had a net margin of 25.01% and a return on equity of 18.95%. View Iradimed's Earnings History.

Iradimed is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Iradimed.

Iradimed updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 6th. The company provided EPS guidance of 0.84-0.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.92. The company issued revenue guidance of $46.3-47.1 million, compared to the consensus revenue estimate of $46.96 million.

Media coverage about IRMD stock has been trending somewhat negative on Wednesday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Iradimed earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Iradimed.

Iradimed saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 500,800 shares, an increase of 8.7% from the January 15th total of 460,900 shares. Based on an average daily volume of 65,300 shares, the days-to-cover ratio is currently 7.7 days. Currently, 9.3% of the shares of the company are short sold. View Iradimed's Current Options Chain.

Some companies that are related to Iradimed include Luminex (LMNX), Cryolife (CRY), Axonics Modulation Technologies (AXNX), Intersect ENT (XENT), Orthofix Medical (OFIX), Orthopediatrics (KIDS), Cerus (CERS), LeMaitre Vascular (LMAT), Anika Therapeutics (ANIK), Antares Pharma (ATRS), SurModics (SRDX), SI-Bone (SIBN), AngioDynamics (ANGO), OraSure Technologies (OSUR) and Inovio Pharmaceuticals (INO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), Paypal (PYPL), Alphabet (GOOG), Mastercard (MA), Palo Alto Networks (PANW), Verizon Communications (VZ), Align Technology (ALGN) and IntriCon (IIN).

Iradimed's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (4.65%), Russell Investments Group Ltd. (2.39%), Cadence Capital Management LLC (0.93%), Parkman Healthcare Partners LLC (0.81%), Marshall Wace LLP (0.58%) and State Street Corp (0.57%). Company insiders that own Iradimed stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, Francis X Casey, John K Mccreery, Louis S Waldman, Monty K Allen, Roger E Susi and Steven M Nardi. View Institutional Ownership Trends for Iradimed.

IRMD stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, AQR Capital Management LLC, Bank of America Corp DE, Cadence Capital Management LLC, Chicago Equity Partners LLC, Navellier & Associates Inc and Fiera Capital Corp. Company insiders that have sold Iradimed company stock in the last year include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen and Steven M Nardi. View Insider Buying and Selling for Iradimed.

IRMD stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Renaissance Technologies LLC, Parkman Healthcare Partners LLC, Rice Hall James & Associates LLC, Bank of Montreal Can, Oxford Asset Management LLP, Algert Global LLC and Acadian Asset Management LLC. View Insider Buying and Selling for Iradimed.

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IRMD stock can currently be purchased for approximately $26.42.

Iradimed has a market capitalization of $303.43 million and generates $38.52 million in revenue each year. The medical equipment provider earns $9.63 million in net income (profit) each year or $0.78 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

The official website for Iradimed is http://www.iradimed.com/.

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]